Telemedicine investment analysis. Toushka Capital invests in Ever Health.

, ,
Integral service around a transaction
BY : Diego GutiérrezJune Mon, 2018

We analyse the investments made in the telemedicine sector from a corporate finance perspective. Ever Health receives a €425,000 equity investment from a Mexican private equity fund, Toushka Capital.

Ever Health and telemedicine

Ever Health is a Madrid-based company, founded in 2015, leader in telemedicine, especially in children's medicine.

Thanks to the complete and innovative paediatric service (KIDSCARE), Ever Health is able to operate in more than 200 educational centres in Spain, serving more than 40,000 children. To provide these services, they have the most advanced technology, state-of-the-art equipment and medical professionals available in the schools during the school day. KIDSCARE can become a key differentiating feature among schools.

In addition to the services provided to the youngest members of the household, they also have the PEOPLECARE programme. This is a service designed to offer both companies and groups the possibility of having a complete medical service in the office and solve daily health problems. Today, Mapfre offers these services and, in turn, is present in companies and shopping centres.

By telemedicine we mean remote medicine. That is to say, it is often impossible for a patient to go to the hospital, which is why Ever Health has created a method, by means of a video call, with which patient and doctor can contact each other without having to go to the nearest hospital or health centre.


Analysis of the operation

Toushka Capital is a Mexican private equity fund that supports the development of companies with a high degree of innovation and that are committed to society, i.e. that seek the good of society. Also known as Social Impact Investment.

Toushka Capital's objective in investing €425,000 in Ever Health is to boost the internationalisation of the company and the expansion of its telemedicine services. In this way, Ever Health's innovative services will expand throughout the Iberian Peninsula and even Latin America.

Toushka Capital, in addition to working with Ever health, participates in other projects with other companies completely different from each other. For example, they collaborate with Estudio 13, a recording studio, they also invest in Vis-À-Vis, the first interactive digital magazine, free of charge and in Spanish, etc. They do not invest in just one sector, they are open to any type of project.

Other companies in the medical technology sector

Company Description Country Amount Date
GRAIL GRAIL develops blood test capable of detecting cancer before symptoms appear USA $300M 21/05/2018
Crescendo Biologics Crescendo Biologics develops its own drug portfolio based on its VH antibody fragment platform. UK $70M 30/04/2018
Iora Health Iora Health is about changing healthcare by changing primary care. USA $100M 21/05/2018
Livongo Livongo employs personalised treatments for diabetes and hypertension. USA $105M 11/04/2018
Constellation Pharmaceuticals Constellation Pharmaceuticals creates new treatments targeting epigenetic mechanisms in tumour and immune cells USA $100M 09/04/2018
The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?